LORIEN ABROMS

Abroms LC et al. Psychosocial Predictors of Smoking Trajectories during Middle and High School, Addiction, in press.

JAMES AHLGREN

Ahlgren JD. 2001. Genetics of pancreatic cancer: clues to pancreatic carcinogenesis. [Editorial]. Cancer Invest 19:98-9.

Ahlgren JD. 2001. Gastrointestinal malignancies. Prim Care 3:647-60.

PATRICIA BERG

Fu S,* Schwartz A, Stevenson H,* Pinzone JJ, Davenport GJ,* Orenstein JM, Gutierrez P, Simmens S, Abraham J, Poola I, Stephan DA and Berg PE. 2003. Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer. Br. Ca. Res. 5:82-87.

Chase MB,* Fu S,* Haga SB,* Davenport G,* Stevenson H,* Do K, Morgan D, Mah A* and Berg PE. 2002. BP1, a homeodomain-containing isoform of DLX4, represses the ?-globin gene. Mol. Cell. Biol. 22: 2505-2514.

Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskanazi AE, Berg PE, Ikegaki N, Kennett RH and Frantz CN. 2001. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res. 61:1073-1079.

Fu S, *Stevenson H, * Strovel JW, Haga SB, *Stamberg J, Do K* and Berg PE. 2001. Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene 278: 131-139

Pinzone JJ et al. 2004. Molecular and cellular determinants of estrogen receptor-a expression. Mol Cell Biol 24:4605-4612.

Man Y-G et al. 2005. Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Ca Research and Treatment. In press.

RACHEL BREM

Jackman RJ, Burbank F, Parker SH, Evans WP, Lechner MC, Richardson TR, Smid AA, Barofsky HB, Lee CH, Goldstein HM, Schilling KJ, Wray AB, Brem RF,Helbich TH, Lehrer DE and Adler SJ. 2001. Stereotactic Breast Biopsy of Nonpalpable Lesions: Determinants of Ductal-carcinoma-in-situ Underestimation Rates. Radiology 218:497-502.

Brem RF, Gatewood OMB. 2001. Impact of Weight Gain and Loss on the Mammogram. The Breast Journal 3:129-133.

Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman SB, Civelek AC. 2002. Evaluation of a High-Resolution Breast-Specific Gamma Camera: A Pilot Study, J Nuclear Medicine 43:909-915.

Brem RF, Baum JK, Kaplan S, Souders S, Naul LG, Hoffmeister J. 2003. Improvement in sensitivity of screening mammography with computer-aided detection (CAD): A multi-institutional trial. AJR American Journal of Roentgenology, in press.

SUSAN CERYAK

Ikegami T, Linan H, Latham PS, Kobayashi K, Ceryak S, Matsuzaki Y, Bouscarel B. 2002. Intestinal alkalinization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea. Cancer Research 62:179-187.

Vilcheck SK, O’Brien T, Pritchard D, Ha L, Ceryak S, Fornsaglio J and Patierno S. 2002. Fanconi anemia complementation group A cells are hypersensitive to chromium (VI)-induced toxicity. Environmental Health Perspectives 110:773-777.

Ha L, Ceryak S and Patierno SR. 2003. Ataxia telangiectasia mutated gene (ATM) is required for both apoptosis and recovery/escape from terminal growth arrest after genotoxic insult with chromium (VI). Journal of Biological Chemistry 278, 17,885-17,894.

O’Brien T, Ceryak S and Patierno SR. 2002. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Special Metals issue of Mutation Research 533:3-36.

Xu, J, Manning FCR, O’Brien TJ, Ceryak S and Patierno SR. 2004. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest. Mol. Cell. Biochem 255:151-160.

Ceryak S, Zingariello C, O’Brien T and Patierno SR. 2003. Induction of pro-apoptotic and cell-cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK. Mol. Cell. Biochem 255:139-149.

Ha L, Ceryak S and Patierno SR. 2004. Generation of S phase-dependent DNA double strand breaks by Cr(VI) exposure: Involvement of ATM in Cr(VI) induction induction of gamma-H2AX. Carcinogenesis 25:2265-2274.

Ha, L et al. 2004. Generation of replication-dependent DNA double strand breaks by Cr(VI) exposure: Involvement of ATM in Cr(VI) induction of gamma-H2AX. Carcinogenesis 25:2265-2274.

EDWARD DEFABO

Noonan FP, Dudek J, Merlino G, De Fabo EC. 2003. Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events. Pigment Cell Res 16:16-25.

Recio, JA, Noonan FP, Takayama H, Anver MR, Duray P, Rush WL, Liotta LA, De Fabo EC, DePinho RA and Merlino G. 2002. Ink4a/Arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res 62:6724-30.

Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC and Merlino G. 2001. Neonatal sunburn and melanoma in mice. Nature 413:271-272.

DeFabo EC et al. 2004. Ultraviolet B but not Ultraviolet A Radiation Initiates Melanoma. Cancer Research 64:6372-6376.

LOUIS DEPALMA

Moid F and DePalma L. 2005. Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature review. Arch Path Lab Med
129:497-501.

SIDNEY FU

Fu S,* Schwartz A, Stevenson H,* Pinzone JJ, Davenport GJ,* Orenstein JM, Gutierrez P, Simmens S, Abraham J, Poola I, Stephan DA and Berg PE. 2003. Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer. Br. Ca. Res 5:82-87.

Fu S, *Stevenson H, * Strovel JW, Haga SB, *Stamberg, J, Do K* and Berg PE 2001. Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene 278:131-139.

ALLAN L. GOLDSTEIN

Moody TW, Tuthill C, Badamchian M and Goldstein AL. 2002. Thymosin ?1 inhibits mammary carcinogenesis in Fisher rats. Peptides 23:1011-1014.

ROBERT HAWLEY

Owens BM et al. 2003. Specific homeodomain-DNA interactions are required for HOX11-mediated transformation. Blood 101:4966-4974.

Dorrell C et al. 2004. Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition. Mol Cell Biol 24:6993-7002.

DONALD HENSON

Albores-Saavedra J, Shukla D, Carrick K and Henson D. 2004. In situ and invasive adenocarcinomas of the gallbladder extending into or arising from Rokitansky-Aschoff sinuses. Am J Surg Pathol 28:621-628.

Henson DE and Albores-Saavedra J. 2004. Checking up on the Surveillance, Epidemiology, and End Results Program. Invited editorial, J Natl Cancer Inst 96:1050-1051.

Henson DE and Patierno SR. 2004. Breast cancer aggressiveness and racial disparity. Meeting Summary, Breast Cancer Treatment and Research 87:291-296.

Henson DE, Dittus C, Younes M, Nguyen H and Albores-Saavedra J. 2004. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000; increase in the signet ring cell type. Arch Pathol Lab Med 128:765-770.

Marchick J and Henson DE. 2005. Correlations between Access to Mammography and Breast Cancer Stage at Diagnosis. Cancer 103:1571-1580.

Henson DE and Albores-Saavedra J. 2005. Pathology of Incipient Neoplasia, in Cancer Chemoprevention, Vol 2: Strategies for Cancer Chemoprevention. Kelloff G, Hawk E, and Sigman CC, editors, pp 69-96, Humana Press, Totowa NJ.

Tsai T, Vu C and Henson DE. 2005. Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Research 15:213-217.

FATAH KASHANCHI

Wu K et al. 2004. Protein profile of Tax-associated complexes. J Biol Chem 279(1):495-508.

Kehn K et al. 2005. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 24(4):525-540.

JOSHUA ADAM KATZ

Katz, JA and Nogueras JJ. 2001. Management of the Malignant Polyp. Clinics In Colon and Rectal Surgery 14:4, 369-378.

KATHERINE KENNEDY

Brandes LM, Lin ZP, Patierno SR and Kennedy KA 2001. Reversal of physiologic stress-induced resistance to Topoisomerase II inhibitors using an inducible phosphorylation site-deficient dominant negative mutant of IkB-alpha. Molecular Pharmacology 60:559-567.

Boller YC, Brandes LM, Russell RL, Lin ZP, Patierno SR and Kennedy KA 2001. Prostaglandin A1 inhibits stress-induced NF-kB activation and reverses resistance to TopoII Inhibitors. Oncology Research 112:383-395.

STEPHAN LADISCH

Li R, Liu Y and Ladisch, S. 2001. Enhancement of Epidermal Growth Factor Signaling and Induction of Src Kinase Activation by Gangliosides. J Biol Chem 276:42782-92.

MacDonald T and Ladisch S. 2001. Antisense to the Integrin Subunit ?v Inhibits Growth and Induces Adhesion-Independent Apoptosis in Medulloblastoma Cells. Exper Cell Res, Anticancer Res 21:3785-3792.

Deng W, Li R, Guerrera, M., Ladisch S. 2002. Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation, Glycobiology, 12(3):145-52.

PATRICIA LATHAM

Ikegami T, Linan H, Latham PS, Kobayashi K, Ceryak S, Matsuzaki Y, Bouscarel B. 2002. Intestinal alkalinization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea. Cancer Research 62:179-187.

JEFFREY LIN

Liao J and Lin J. 2001. Estrogen receptor expression in a low grade endometrial stromal sarcoma after tamoxifen therapy. Eur J Gynaecol Oncol 22:417419.

TOBEY MACDONALD

Mintz MB et al. 2005. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Research 65:1748-1754.

Khatua S et al. 2003. Overexpression of the EGFR/FKBP12/HIF2a pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Research 63(8):
1865-1870.

H. GEORGE MANDEL

OBrien TJ, Mandel HG, Pritchard DE and Patierno SR. 2002. Critical role of chromium(Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry 41:12529-12537.

MILCHO MINCHEFF

Mincheff M, Altankova I, Zoubak S, Tchakarov S, Botev Ch, Petrov St, Krusteva E, Kurteva G, Kurtev P, Dimitrov V, Ilieva M, Georgiev G, Lissitchkov T and Chernozemski I. 2001. In vivo Transfection and/or Cross Priming of Dendritic Cells by DNA and Adenoviral Immunizations for Immunotherapy of Cancer – Changes in Peripheral Mononuclear Subsets and Intracellular IL-4 and IFN-? Lymphokine Profile. Critical Reviews in Oncology/Hematology 39:125-132.

Altankova I, Mincheff M, Tchakarov St, Zoubak S, BotevCh, Krusteva E, Kurteva G, Kurtev P, Dimitrov V, Pomakov Y, Bocheva St, Chernozemski I, Lissitchkov T and Meryman HT. 2002. Immune cell phenotypes and T-1/T-2 cytokine profile of peripheral blood mononuclear cells as parameters of immune dysfunction in advanced cancer patients. Clin Appl Immunology 1:34-41.

Dzik S, Mincheff M and Puppo F. Apoptosis, transforming growth factor-?, and the immunosuppressive effect of transfusion. 2002. Transfusion 42:1221.

Dzik WH, Mincheff M and Puppo F. 2002. An alternative mechanism for the immunosuppressive effect of transfusion. Vox Sang 83 Suppl 1:417-9.

Mincheff M et al. 2005. Depletion of CD25+ Cells from Human T-Cell Enriched Fraction Eliminates Immunodominance during Priming and Boosting with Genetically Modified Dendritic Cells. Cancer Gene Therapy 12:185.

Todorova K et al. 2005. Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded. Cancer Immunity 5:1.

FRANCES NOONAN

Noonan FP, Dudek J, Merlino G and De Fabo EC. 2003. Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events. Pigment Cell Res. 16:16-25.

Merlino G and Noonan FP. 2003. Modeling Gene-Environment Interactions In Malignant Melanoma. Trends in Molecular Medicine 9:102-108.

Jhappan C, Noonan FP and Merlino G. 2003. Ultraviolet Radiation and Cutaneous Malignant Melanoma. Oncogene 22(20):3099-119.

Recio JA, Noonan FP, Takayama H, Anver MR, Duray P, Rush WL, Lindner G, De Fabo EC, DePinho RA and Merlino G. 2002. Ink4a/Arf Deficiency Promotes Ultraviolet Radiation-induced Melanomagenesis. Cancer Res 62:6724-30.

Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, Lindner G, De Fabo EC and Merlino G. 2001. Neonatal sunburn and melanoma in mice. Nature 413:271-2.

TRAVIS O’BRIEN

Vilcheck SK, O’Brien T, Pritchard D, Ha L, Ceryak S, Fornsaglio J and Patierno S. 2002. Fanconi anemia complementation group A cells are hypersensitive to chromium (VI)-induced toxicity. Environmental Health Perspectives 110:773-777.

O’Brien T, Ceryak S and Patierno SR. 2003. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Special Metals issue of Mutation Research 533:3-36.

Xu J, Manning FCR, O’Brien TJ, Ceryak S and Patierno SR. 2004. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest. Mol. Cell. Biochem 255:151-160.

Ceryak S, Zingariello C, O’Brien T and Patierno SR. 2003. Induction of pro-apoptotic and cell-cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK. Mol. Cell. Biochem 255:139-149.

OBrien TJ, Mandel HG, Pritchard DE and Patierno SR. 2002. Critical role of chromium(Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry 41:12529-12537.

BRUCE ORKIN

Vricella LA and Orkin BA. Transanal endoscopic microsurgery and colonoscopy. Laparoscopy for Surgery of the Abdomen. Bruce V. MacFadyen, Jr., Ed. Springer Verlag. Pp. 437-445. New York.

STEVEN PATIERNO

Patierno SR, Manyak MJ, Fernandez PM, Baker AB, Weeraratna AT, Chou D, Szlyk G, Geib KS, Walsh C and Patteras J. 2002. Uteroglobin: A potential novel tumor suppressor and molecular therapeutic for prostate cancer. Clinical Prostate Cancer 1, 2: 118-124.

Vilcheck SK, O’Brien T, Pritchard D, Ha L, Ceryak S, Fornsaglio J and Patierno S. 2002. Fanconi anemia complementation group A cells are hypersensitive to chromium (VI)-induced toxicity. Environmental Health Perspectives 110:773-777.

Lugassy C, Kleinman HK, Fernandez PM, Patierno SR, Webber MM, Ghanem G, Spatz A and Barnhill RL. 2002. Human melanoma cell migration along capillary-like structures in vitro: A new dynamic model for studying extravascular migratory metastasis. J. Invest. Dermatol. 119(3):703-704.

Ha L, Ceryak S and Patierno SR. 2003. Ataxia telangiectasia mutated gene (ATM) is required for both apoptosis and recovery/escape from terminal growth arrest after genotoxic insult with chromium (VI). Journal of Biological Chemistry 278:17,885-17,894.

O’Brien T, Ceryak S and Patierno SR. 2003. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Special Metals issue of Mutation Research 533:3-36.

Xu J, Manning FCR, O’Brien TJ, Ceryak S and Patierno SR. 2004. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest. Mol. Cell. Biochem 255:151-160.

Ceryak S, Zingariello C, O’Brien T and Patierno SR. 2003. Induction of pro-apoptotic and cell-cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK. Mol. Cell. Biochem 255:139-149.

Ha L, Ceryak S and Patierno SR. 2004. Generation of S phase-dependent DNA double strand breaks by Cr(VI) exposure: Involvement of ATM in Cr(VI) induction induction of gamma-H2AX. Carcinogenesis 25:2265-2274.

Fernandez PM, Patierno SR and Rickles FR. 2004. Tumor angiogenesis and blood coagulation. In: Lugassy G, Falanga A, Kakkar AJ, Rickles FR (eds): Thrombosis and Cancer, Martin Dunitz Ltd, London, pg 69-99.

Rickles FR, Patierno SR and Fernandez PM. 2003. Targeting the endothelium in cancer- the importance of the interaction of hemostatic mechanisms and the vascular wall for tumor growth and angiogenesis. Pathophysiology of Haemostasis and Thrombosis 33:1-10.

Lugassy C, Kleinman HK, Engbring JA, Welch DR, Harms JF, Rufner R, Ghanem G, Barnhill RL and Patierno SR. 2004. Pericyte-like location of GFP-tagged melanoma cells. Ex vivo and in vivo studies of extravascular migratory metastasis. A. Journal Pathology 164(4):1191-1198.

Henson D and Patierno SR. 2004. Breast cancer aggressiveness and racial disparity. Breast Cancer Research and Treatment, Breast Cancer Research and Treatment 87:291-296.

JOHN QUACKENBUSH

Hedge P, Qi R, Gaspard R, Abernathy K, Dharap S, Earle-Hughes J, Gay C, Nwokekeh NU, Chen T, Saeed AI, Sharov V, Lee NH, Yeatman TJ and Quackenbush J. 2001. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res 61(21):7792-7797.

Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D and Yeatman TJ. 2002. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94(7):513-521.

Malek RL, Iriby RB, Guo QM, Lee K, Wong S, He M, Tsai J, Frank B, Liu ET, Quackenbush J, Jove R, Yeatman TJ and Lee NH. 2002. Identification of Src transformation fingerprint in human colon cancer. Oncogene 21(47):7256-7265.

FREDERICK RICKLES

Fernandez P, Patierno S and Rickles FR. 2004. Tissue factor and fibrin in tumor angiogenesis. Sem Thromb Haem 30(1):31-44.

Falanga A and Rickles FR. 2003. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukemia. Best Pract Res Clin Haematol. 16(3):463-82.

Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Math M, Haley S, Kovacs MJ and Gent M, for the CLOT Investigators. 2003. A randomized comparison of low-molecular-weight heparin versus oral anticoagulants for the long-term treatment of venous thromboemoblism in patients with cancer (CLOT in Cancer Trial). N Engl J Med 349(2):146-53.

Rickles FR, Patierno S and Fernandez P. 2003. Tissue factor, thrombin and cancer. Chest 124(3 Suppl):58S-68S.

NADER SADEGHI

Al-Sebeih K, Sadeghi N and Al-Dhahari S. 2001. Bilateral chylothorax following neck dissection: a new method of treatment. Ann Otol Rhinol Laryngol 110 (4):381-384.

Sadeghi N. 2001. Endoscopic medial maxillectomy in the management of inverting papilloma. Indications and Technique. Meeting abstract. J Otolaryngol 30:54.

Abou-Khalil S, Hier M, Sadeghi N, Duclos M, Donath D and Black M. 2001. Brachytherapy Implantation during Free Flap Reconstructive Procedures. Meeting abstract. J Otolaryngol 30: 59.

Yoskovitch A, Nguyen LH, Sadeghi N and Auger M. 2001. Renal cell carcinoma presenting as a mandibular mass. Otolaryngol Head Neck Surg 125(6):654-5.

Sadeghi N, Al-Dhahri S and Manoukian JJ. 2003. Transnasal Endoscopic Medial Maxillectomy (TEMM) for Inverting Papilloma. Laryngoscope 113: 749-754.

ROBERT STEVEN SIEGEL

Wison WR, Siegel RS, Harisiadis LA, Davis DO, Nguyen HH and Bank WO. 2001. High-dose Intra-Arterial Cisplatin Therapy followed by Radiation Therapy for Advanced Squamous Cell Carcinoma of the Head and Neck. Arch Otolaryngol Head Neck Surgery 127(7): 809-12.

SAMUEL SIMMENS

Kang HK, Simmens S, Mahan CM, Young HA, Lee KY, Levine PL and Murphy FM. 2002. Evidence for a Deployment Related Gulf War Syndrome by Factor Analysis. Archives of Environmental Health 57:61-68.

Zook BC and Simmens SJ. 2001. The Effects of 860 MHz Radiofrequency Irradiation on the Induction or Promotion of Brain Tumors and other Neoplasms in Rats. Radiation Research 155:572-583.

HEATHER YOUNG

Weinstein A, Pan J, Richardson P, Norton D, Young HA and Rochon J. 2001. A Controlled Trial of Acupuncture for Carpal Tunnel Syndrome. Alt Ther Health Med 7:S35.

Kim JH, Sarani B, Orkin BA, Young HA, White J, Tannebaum I, Stein S and Bennett B. 2001. HIV-Positive Patients with Anal Carcinoma Have Poorer Treatment Tolerance and Outcomes Than HIV-Negative Patients. Diseases of the Colon and Rectum 44:1496 1502.

Sklar PA, Bathgate SL, Young HA and Parenti DM. 2001. Care of HIV-infected pregnant women in maternal-fetal medicine programs. Infectious Diseases in Obstetrics and Gynecology 9:81-87.

Hotez PJ, Bin Z, Jin Q, Bethony J, Hawdon JM, Young HA, Simmens SJ, Hitzelberg R and Zook BC. 2002. Clinical Courses of Canine Hookworm Infections Following Three Different Oral Doses of Third-Stage Infective Larvae of Ancylostoma caninum. Comparitve Parisitology 69:72-80.

Kang HK, Mahan CM, Lee K, Murphy F, Simmens SJ, Young HA and Levine PH. 2002. Evidence for a Deployment Related Gulf War Syndrome by Factor Analysis. The Archives of Environmental Health 57:61-69.

Cochran JC, Prindle V, Young HA, Kumar MH, Tom S, Petraco NDK, Mohoro C and Kelley B. 2002. Alkyl- and Acyl-Substituted Vinylstannanes: Synthesis and Reactivity in Electrophilic Substitution Reactions. Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry 32(5):885-902.

Mills PK et al. 2004. Perineal Talc Exposure and Epithelial Ovarian Cancer Risk in the Central Valley of California. Intl Journal Cancer 112(3):458-64.

Levine PH et al. 2005. Is testicular cancer related to Gulf War Deployment: Evidence from a Pilot Population-based study of Gulf War Era veterans and Cancer? Military Medicine 170(2):149-153.